Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06065046Phase 2Recruiting

Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

Role: collaborator

NCT05487417Phase 4Recruiting

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

Role: collaborator

NCT06392503Recruiting

Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis

Role: collaborator

All 3 trials loaded